Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice - Concepedia

Concepedia

Publication | Closed Access

Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice

49

Citations

21

References

2020

Year

Zhongwen Feng, Lijun Pang, Siyun Chen, Xiaohong Pang, Yushen Huang, Qian Qiao, Yinglian Wang, Sayyaphone Vonglorkham, Quanfang Huang, Xing Lin,

International Immunopharmacology

InflammationMetabolic SyndromePi3k/akt PathwaysHepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyImmune RegulationImmunologyChronic InflammationPathologyC57bl/6j MiceHepatology InflammationLiver DiseaseFatty Liver DiseaseMetabolic SignalingMedicineDrug-induced Liver InjuryHealth Sciences

References

	Year	Citations

Page 1

Page 1